EVOK Chart
- 52-Week Range: $0.25 - $1.46
- Market Capitalization: $12.04M
- Short Percentage: 0%
- Target Price: $6.50
- Shares Outstanding: 40.12M
- Next Earnings: Nov 30
Catalysts
CategoryCatalyst
Earnings
EVOK released their earnings report for the previous quarter and provided guidance on the current and upcoming quarters.
News and Press Releases
- Evoke Pharma, Inc. (EVOK) CEO David Gonyer on Q1 2022 Results - Earnings Call TranscriptSeeking Alpha | May 10th
- Evoke Pharma to Report First Quarter 2022 Financial Results on May 10, 2022GlobeNewsWire | May 3rd
- Evoke Shares Skyrocket On New FDA Market Exclusivity For Gimoti Nasal SprayBenzinga | April 26th
- Evoke Pharma, Inc. (EVOK) CEO Dave Gonyer on Q4 2021 Results - Earnings Call TranscriptSeeking Alpha | March 8th
- Evoke Pharma Reports Fourth Quarter and Full Year 2021 Financial ResultsGlobeNewsWire | March 8th
- Evoke Pharma to Report Fourth Quarter and Full Year 2021 Financial Results on March 8, 2022GlobeNewsWire | March 1st
- Evoke Pharma and EVERSANA Extend Commercialization Partnership to Further Support GIMOTIGlobeNewsWire | February 2nd
- Evoke Pharma's (EVOK) CEO Dave Gonyer on Q3 2021 Results - Earnings Call TranscriptSeeking Alpha | November 10th
Company Info
Website: https://www.evokepharma.com
Address: 420 Stevens Avenue, Solana Beach, CA, United States, 92075
Sector: Healthcare
Industry: Drug Manufacturers—Specialty & Generic
Full time employees: 4
Address: 420 Stevens Avenue, Solana Beach, CA, United States, 92075
Sector: Healthcare
Industry: Drug Manufacturers—Specialty & Generic
Full time employees: 4
$EVOK taking off soon
$EVOK oh my!
$EVOK We will not sell!
$EVOK hello
please hold.
$EVOK adding next Friday